13F 机构持仓

Elmind Capital, LP

NEW YORK NY · SEC CIK 0002052213

2026Q22026Q1 更早 9 个季度 🔒
$3.52亿2026Q1 申报市值
34持仓数
68.8%前十大占比 · 第一大 12.8%
2 / 2新建仓 / 清仓
申报市值走势$3.98亿2026Q2
26Q126Q2

付费方案可看全部 11 个季度的走势 🔒

前十大持仓 占组合比例

COGT 12.8%
SNDX 12.3%
CLDX 7.8%
CTMX 6.1%
KALVISTA PHARM 5.8%
CGON 5.6%
VERA 5.5%
PCVX 5.2%
PHVS 3.8%
TYRA 3.8%

2026Q1 买入最多 按季末市值估算

CTMX 加仓+$1,809.50万
DBVT 新建仓+$553.59万
KALVISTA PHARMAC 加仓+$442.86万
CGEM 加仓+$312.62万
ALMS 新建仓+$286.39万

2026Q1 卖出最多 按季末市值估算

CGON 减仓-$1,358.34万
BCRX 减仓-$1,094.80万
DYNAVAX TECHNOLO 清仓-$1,045.69万
VRDN 减仓-$633.16万
LQDA 清仓-$310.41万

2026Q1 持仓明细 点表头排序

导出 CSV 🔒
代码名称市值 ▼占比股数变动股数变动估算买卖额操作
COGT COGENT BIOSCIENCES INC $4,506.18万12.79%1,170,740 00.0% — 不变
SNDX SYNDAX PHARMACEUTICALS INC $4,333.28万12.30%1,855,000 00.0% — 不变
CLDX CELLDEX THERAPEUTICS INC NEW $2,743.78万7.79%865,000 00.0% — 不变
CTMX CYTOMX THERAPEUTICS INC. $2,138.50万6.07%4,550,000 3,850,000550.0% $1,809.50万 加仓
— KALVISTA PHARMACEUTICALS INC $2,055.88万5.84%1,021,300 220,00027.5% $442.86万 加仓
CGON CG ONCOLOGY INC $1,974.90万5.61%291,800 -200,700-40.8% -$1,358.34万 减仓
VERA VERA THERAPEUTICS INC $1,941.10万5.51%482,500 00.0% — 不变
PCVX VAXCYTE INC $1,839.18万5.22%316,500 25,0008.6% $145.28万 加仓
PHVS PHARVARIS N V $1,343.99万3.82%475,750 00.0% — 不变
TYRA TYRA BIOSCIENCES INC $1,340.50万3.81%350,000 00.0% — 不变
BEAM BEAM THERAPEUTICS INC $1,135.11万3.22%476,338 00.0% — 不变
VRDN VIRIDIAN THERAPEUTICS INC $1,046.33万2.97%534,931 -323,700-37.7% -$633.16万 减仓
BCRX BIOCRYST PHARMACEUTICALS INC $952.00万2.70%1,000,000 -1,150,000-53.5% -$1,094.80万 减仓
UTHR UNITED THERAPEUTICS CORP DEL $889.47万2.53%15,000 4,00036.4% $237.19万 加仓
CGEM CULLINAN THERAPEUTICS INC $753.13万2.14%530,000 220,00071.0% $312.62万 加仓
NRIX NURIX THERAPEUTICS INC $713.00万2.02%460,000 00.0% — 不变
MBX MBX BIOSCIENCES INC $629.84万1.79%211,000 00.0% — 不变
KRYS KRYSTAL BIOTECH INC $568.30万1.61%22,000 00.0% — 不变
DBVT DBV TECHNOLOGIES S A $553.59万1.57%265,000 265,000— $553.59万 新建仓
RLAY RELAY THERAPEUTICS INC $534.26万1.52%536,946 00.0% — 不变
TVTX TRAVERE THERAPEUTICS INC $527.65万1.50%177,600 67,60061.5% $200.84万 加仓
PTGX PROTAGONIST THERAPEUTICS INC $400.52万1.14%38,000 00.0% — 不变
URGN UROGEN PHARMA LTD $395.56万1.12%220,000 120,000120.0% $215.76万 加仓
ALMS ALUMIS INC $286.39万0.81%130,000 130,000— $286.39万 新建仓
BMRN BIOMARIN PHARMACEUTICAL INC $265.50万0.75%47,000 -35,000-42.7% -$197.72万 减仓
DSGN DESIGN THERAPEUTICS INC $221.21万0.63%207,900 00.0% — 不变
— APELLIS PHARMACEUTICALS INC $201.15万0.57%50,000 00.0% — 不变
ALEC ALECTOR INC $193.50万0.55%900,000 00.0% — 不变
IMCR IMMUNOCORE HLDGS PLC $175.62万0.50%58,248 00.0% — 不变
AMLX AMYLYX PHARMACEUTICALS INC $155.68万0.44%112,000 00.0% — 不变
— ENGENE HOLDINGS INC $143.01万0.41%210,000 00.0% — 不变
WVE WAVE LIFE SCIENCES LTD $128.94万0.37%177,846 -270,000-60.3% -$195.75万 减仓
— SUPERNUS PHARMACEUTICALS $103.38万0.29%20,000 00.0% — 不变
EWTX EDGEWISE THERAPEUTICS INC $31.50万0.09%10,000 -20,000-66.7% -$63.00万 减仓
— DYNAVAX TECHNOLOGIES CORP $00.00%0 -679,900-100.0% -$1,045.69万 清仓
LQDA LIQUIDIA CORPORATION $00.00%0 -90,000-100.0% -$310.41万 清仓